84 (PB074) - Identification of STX-721, an EGFR exon 20 mutant inhibitor with superior selectivity and a potential best-in-class profile

Autor: Pagliarini, R., Milgram, B.C., Borrelli, D.R., Brooijmans, N., Huff, M.R., Ito, T., Jonsson, P., Ladd, B., O’Hearn, E., Wang, W., Kuzmic, P., Bellier, J., Hata, A.N., Guzman-Perez, A., Stuart, D.D.
Zdroj: In European Journal of Cancer October 2022 174 Supplement 1:S29-S30
Databáze: ScienceDirect